Your browser doesn't support javascript.
loading
Body mass index and insulin use as identifiers of high-cost patients with type 2 diabetes: A retrospective analysis of electronic health records linked to insurance claims data.
Johnston, Stephen S; Ammann, Eric M; Kashyap, Sangeetha R; Stokes, Andrew; Hsiao, Carine Chia-Wen; Daskiran, Mehmet; Scamuffa, Robin.
Afiliação
  • Johnston SS; Epidemiology, Medical Devices, Johnson & Johnson, New Brunswick, New Jersey.
  • Ammann EM; Epidemiology, Medical Devices, Johnson & Johnson, Titusville, New Jersey.
  • Kashyap SR; Cleveland Clinic Foundation, Cleveland, Ohio.
  • Stokes A; Department of Global Health, School of Public Health, Boston University, Boston, Massachusetts.
  • Hsiao CC; Franchise Health Economics and Market Access, Ethicon Inc., Johnson & Johnson, Somerville, New Jersey.
  • Daskiran M; Epidemiology, Johnson & Johnson, Titusville, New Jersey.
  • Scamuffa R; Clinical Research, Ethicon Inc., Cincinnati, Ohio.
Diabetes Obes Metab ; 21(6): 1419-1428, 2019 06.
Article em En | MEDLINE | ID: mdl-30768824

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Índice de Massa Corporal / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Insulina Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Índice de Massa Corporal / Diabetes Mellitus Tipo 2 / Hipoglicemiantes / Insulina Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article